Rigel Pharmaceuticals (RIGL) Files $200M Mixed Shelf
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Join SI Premium – FREE
Rigel Pharmaceuticals (Nasdaq: RIGL) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $200 million of Common Stock, Warrants, or a combination of the two.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BKV registers 5.3 million shares for resale tied to power JV deal
- American EcoFuels plans up to 584 new patent filings for fuel tech
- Kimbell Royalty raises 2026 output guidance after two acquisitions
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
